CSL Honoured as Overall Winner of the 2025 Facility of the Year Awards by the International Society for Pharmaceutical Engineering (ISPE)
- CSL's base fractionation facility in Broadmeadows, Australia, has been awarded the Overall Winner of the 2025 Facility of the Year Award by the International Society for Pharmaceutical Engineering .
- The award highlights CSL's commitment to innovation, operational excellence, and sustainability, establishing the facility as a global benchmark in biopharmaceutical manufacturing.
- The facility features sustainable technologies, including reusable filters and energy-efficient systems, contributing to CSL's goals of responsible innovation and long-term impact.
- In May 2025, the facility also received the ISPE FOYA award in the Pharma 4.0 category for its advanced digital technologies and automation.
44 Articles
44 Articles
Vertolaye, a village of 800 inhabitants in Puy-de-Dôme, becomes the symbol of the European pharmaceutical revival, thanks to the Med4Cure project. The Euroapi factory will produce medicines once made in Asia.
CSL Honoured as Overall Winner of the 2025 Facility of the Year Awards by the International Society for Pharmaceutical Engineering (ISPE)
Setting new standards in responsible innovation, CSL's Broadmeadows facility blends Pharma 4.0™ principles with sustainable design to transform plasma manufacturing
Pharmaceutical Label Manufacturers Evaluated on Regulatory Compliance, Material Performance, and Serialization Capabilities
A recent analysis compared leading pharmaceutical label […] The post Pharmaceutical Label Manufacturers Evaluated on Regulatory Compliance, Material Performance, and Serialization Capabilities first appeared on GeneOnline News. The post Pharmaceutical Label Manufacturers Evaluated on Regulatory Compliance, Material Performance, and Serialization Capabilities appeared first on GeneOnline News.
Coverage Details
Bias Distribution
- 72% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium

















